Gan & Lee Pharmaceuticals
http://www.ganlee.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Gan & Lee Pharmaceuticals
Uncertain Times: New Lockdowns, Ukraine Challenge Chinese Pharma
As residents of China's largest city brace for a possible prolonged lockdown, the gathering COVID-19 outbreak is set to cause some pharma disruption in the country, while broader geopolitical factors including Ukraine are hindering the industry's global ambitions.
Uncertain Times: New Lockdowns, Ukraine Challenge Chinese Pharma
As residents of China's largest city brace for a possible prolonged lockdown, the gathering COVID-19 outbreak is set to cause some pharma disruption in the country, while broader geopolitical factors including Ukraine are hindering the industry's global ambitions.
China’s First Insulin Tender Hits Multinationals Hard
An average overall price reduction of 48% for insulin products in China is expected to generate annual savings of $1.4bn through 2023, but multinational pharma firms will be hit hard by the bidding process.
China Offers Level Field In Trade Pact Bid But Multiple Pharma Barriers Remain
China has signaled that it will offer a more level playing field to foreign players as part of a bid to join a major regional trade pact but some see the gesture as offering little real relief and high hurdles remain.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Gan & Lee Pharmaceuticals Shandong Co., Ltd
- Gangan Medical Technology Jiangsu Co., Ltd.